Study on Extending Exclusive Access to Clinical Trial Data First to Estimate Impacts

By Dana McMurtry on January 13, 2011 4:03 PM

Goldman et al. publish new study in January Health Affairs demonstrating that extending the data exclusivity term for conventional drugs would positively impact innovation, longevity and social welfare.

Categories:

News

  • Study on Extending Exclusive Access to Clinical Trial Data First to Estimate Impacts

    Goldman et al. publish new study in January Health Affairs demonstrating that extending the data exclusivity term for conventional drugs would positively impact innovation, longevity and social welfare.

  • Study Finds Higher STD Rates Among Users of Erectile Dysfunction Drugs

    Anupam Jena, M.D. and Dana Goldman, Ph.D. analyzed 1.4 million insurance records of men over 40 and found that those who used ED drugs were more likely to have STDs than non-users. Results suggest counseling on safer sex practices important for older men.

  • How To Live 100 Years

    For TIME, Dana Goldman et al. use their innovative Future Elderly Model to simulate an hypothetical long-life pill, getting dramatic economic and health spending results.

  • USC & RAND Economists Win Garfield Prize
    USC & RAND Economists Win Garfield Prize Darius Lakdawalla and his co-authors received the 2009 Eugene Garfield Economic Impact on Medical and Health Research award for their study on how methods to lower drug prices affect medical innovation and, ultimately,...